Business

According to Harm Reduction Therapeutics (HRT), the court handling the bankruptcy of Purdue Pharma has approved an additional $9 million in Purdue funds to be used by HRT to prepare for possible commercialization of RiVive… Read more . . .

US start-up Allermi said that it has raised $3.5 million in a seed round led by Nelstone Ventures for “the world’s first custom approach offered by Allermi that combines and adjusts the doses of multiple… Read more . . .

According to Acorda Therapeutics, Esteve Pharmaceuticals has launched Acorda’s Inbrija inhaled dry powder levodopa in Spain. Acorda announced the Spanish distribution deal with Esteve in July 2021. Inbrija DPI has been approved in Europe for… Read more . . .

Akorn Pharmaceuticals has filed for Chapter 7 bankruptcy and closed all US facilities, including its manufacturing plant in Decatur, IL. A Decatur newspaper, the Herald Review, published a video of Akorn President and CEO Douglas… Read more . . .

Oragenics has announced a new license agreement with Inspirevax (formerly Biodextris) for use of Inspirevax’s BDX301 intranasal mucosal adjuvant in Oragenic’s NT-CoV2-1 intranasal COVID-19 vaccine candidate. The company said that the deal includes payments for… Read more . . .

According to Vistagen, the US Patent and Trademark Office (USPTO) has granted US Patent 11,419,881 covering the company’s PH80 pherine nasal spray for treatment of migraine until 2040. The company says that “PH80 is an investigational pherine nasal… Read more . . .

According to ARS Pharmaceuticals, Recordati has returned the European marketing rights to ARS-1 epinephrine nasal spray (Neffy) in return for an unspecified amount up front plus future milestone payments connected to European approval and launch… Read more . . .

Impel Pharmaceuticals announced that it will cut 16% of its workforce and halt development of INP105 intranasal olanzapine for the treatment of agitation in autism spectrum disorder. The company also said that its Chief Medical Officer,… Read more . . .